medigraphic.com

2011, Número 3

<< Anterior Siguiente >>

Rev Cuba Endoc 2011; 22 (3)


Frecuencia y caracterización del síndrome metabólico según criterios de la Federación Internacional de Diabetes en familiares de primer grado de personas con diabetes tipo 1

Parlá SJ, Cabrera RE, Marichal MS, Arranz CC, Domínguez AE, González FP, Vera GM

Idioma: Español
Referencias bibliográficas: 45
Paginas: 196-209
Archivo PDF: 95.83 Kb.


RESUMEN

Introducción: el síndrome metabólico se ha definido como la asociación de varios factores precursores de enfermedad cardiovascular y de diabetes mellitus tipo 2.
Objetivo: determinar la frecuencia de síndrome metabólico, según los criterios de la Federación Internacional de Diabetes en familiares de primer grado de diabéticos tipo 1.
Métodos: se seleccionaron 96 adultos y 97 adolescentes, se les aplicó un cuestionario, y se les realizó un examen físico general. Además, se les realizaron determinaciones en ayunas de glucosa, insulina, colesterol, triglicéridos y HDL colesterol, y se calculó el índice de resistencia a la insulina.
Resultados: la frecuencia del síndrome metabólico fue mayor en los adultos 17,7 % (17/96) que en los adolescentes 3,09 % (3/97), y la resistencia a la insulina en los adultos fue similar en los sujetos con y sin síndrome metabólico. La historia familiar de enfermedad cardiovascular, diabetes mellitus tipo 2, obesidad, dislipidemia e hipertensión arterial no está asociada con la presencia del síndrome metabólico en los familiares de primer grado de diabéticos tipo 1.
Conclusiones: el síndrome metabólico, según los criterios de la Federación Internacional de Diabetes, es más frecuente en los adultos que en los adolescentes familiares de primer grado de diabéticos tipo 1, y la resistencia a la insulina en estos sujetos no está exclusivamente asociada al síndrome metabólico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Eckel RH, Gruñid SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1 415-28.

  2. Wilson PW, D'Agostino RB, Parise H. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3 066-72.

  3. Reaven G. Banting lecture: role of insulin resistance in human disease. Diabetes. 1988;37:1 595-607.

  4. Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations. Diabetes Vasc Dis Res. 2007;4:13-9.

  5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expret Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2 486-97.

  6. Alberti KG, Zimmet PZ, Shaw JE. The Metabolic Syndrome-A New Wordlwide Definition from the International Diabetes Federation Consensus. Lancet. 2005;366:1 059-62.

  7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9

  8. Zimmet Paul, Alberti G. El síndrome metabólico en niños y adolescentes: el consenso de la FID. Diabetes Voice. 2007;52:29-32.

  9. Yang X, Jansson PA, Pellme F, Laakso M, Smith U. Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity. Obes Res. 2005;13:813-7.

  10. Hamid YH, Rose CS, Urhammer SA, Glumer C, Nolsoe R, Kristiansen OP, et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia. 2005;48:251-60.

  11. Barja S, Hodgson M, Acosta A, Arteaga A. Intolerancia a la glucosa en niños obesos. Rev Med Chile. 2003;131:419-26.

  12. Mazza C, Ozuna B, Krochik A, Raujo MB. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in obese Argentinean children and adolescents. J Pediatr Endocrinol Metab. 2005;18:491-8.

  13. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia. 2004;47:1 661-7.

  14. Polly J, Jefrey L, Edwin AM. Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care. 2008;31:146-9.

  15. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia. 2001;44:914-22.

  16. Kibirige M, Metcalf B, Renuka R, Wilkin TJ. Testing the accelerator hypothesis. The relationship between body mass and age at diagnosis of type 1 diabetes. Diabetes Care. 2003;26:2 865-70.

  17. Betts P, Mulligan J, Ward P, Smith B, Wilkin T. Increasing weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the "accelerator hypothesis" (2). Diabet Med. 2005;22:144-51.

  18. Kulmala P, Savola K, Reijonen H, Veijola R, Vähäsalo P, Karjalainen J, et al, and the Childhood Diabetes in Finland Study Group. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group. Diabetes. 2000;49:48-58.

  19. Reindel J, Zabder E, Heinke P, Kohnert KD, Allwardt C, Kerner W. The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity. Herz. 2004;29:463-9.

  20. Cole TJ. Weight-stature indices to measure underweight, overweight and obesity. Anthropometric assessment of nutritional status. Nueva York: Himes JH (ed.) Wiley- Liss; 1991. p. 83-111.

  21. Mathews DR, Hosker JP, Rudenki AS, Nailor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and Beta Cell Function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412-9.

  22. Arranz Calzado C, Rodríguez Pendás B, Álvarez Álvarez A, Reyes Durán A, de Dios Despaigne R, González Suárez R. Valores de referencia para el índice de resistencia a la insulina del modelo homeostático (RIHOMA) estimado a partir de los resultados de una muestra mixta hospitalaria. Revista de la Asociación Latinoamericana de Diabetes. 2007;(XV):121.

  23. Day C. Metabolic syndrome, or What you will; definitions and epidemiology. Diabetes and Vascular Disease Research. 2007;4:32-8.

  24. Ko GT, Cockram CS, Chow CC. Metabolic syndrome by the International Diabetes Federation definition in Hong Kong Chinese. Diabetes Res Clin Pract. 2006;73:58-64.

  25. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care. 2005;28:2 588-9.

  26. Athyros VG, Ganotakis Es, Elisaf M, Mikhailidis DP. The prevalence of the metabolic syndrome using the National Cholesterol Education Program and International Diabetes Federation definitions. Curr Med Res Opin. 2005;21:1 157-9.

  27. Meis SB, Schuster D, Gaillar T, Osei K. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American pateints with type 2 diabetes: African American triglicerides-HDL-c and insulin resistance paradox. Ethn Dis. 2006 Autumn;16(4):830-6.

  28. Siewert S, Filipuzzi S, Codazzi L, Gonzalez I, Ojeda MS. Impact of metabolic syndrome risk factors in first-degree relatives of type 2 diabetic patients. Rev Diabet Stud. 2007 fall;4(3):177-84.

  29. Koehler C, Ott P, Benke I, Hanefeld M, DIG Study Group. Comparison of the prevalence of the metabolic syndrome by WHO,AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study. Horm Metab Res. 2007 sep;39(9):632-5.

  30. Thorn LM, Forsblon C. Metabolic Syndrome in type 1 diabetes association with diabetic nephropathy and glycemic control (the Finn Diane Study). Diabetes Care. 2005;28:2 019-24.

  31. Davis TM, Bruce DG, Davis WA. Prevalence and prognostic implications of the metabolic syndrome in community-based patiens with type 1 diabetes: The Fremantle Diabetes Study. Diabetes Res Clin Pract. 2007;78:412-7.

  32. De Ferranti S, Stavroula KO. Epidemilogy of paediatric metabolic syndrome and type 2 diabetes mellitus. Diabetes Vasc Dis Res. 2007;4:285-96.

  33. Cheung BM, Wat NM, Man YB, Tam S, Cheng CH, Leung GM, et al. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). Am J Hypertens. 2008 Jan;21(1):17-22.

  34. Kanjilal S,Shanker J,Rao VS,Khadrinarasimhaih NB,Mukherjee M, Iyengar SS, et al. Prevalence and component analysis of metabolic syndrome: an Indian atherosclerosis research study perspective.Vasc Health Risk Manag. 2008;4(1):189- 97.

  35. Jassen I, Heymsfield S, Allison D, Kotler D, Ross R. Body mass index and waist circumference, waist-to-hip ratio and body mass index as indication of cardiovascular risk factors: The Canadian Health Surveys. Int J Obes Relat Metab Disord. 2001;25:652-61.

  36. Maffeis C, Pietrobelli A, Grezzani A, Provera S, Tato L. Waist circumference and cardiovascular risk fators in prepuberal children. Obes Res. 2001;9:179-87.

  37. Savva S, Tornaritis M. Waist circunference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord. 2000;24:1 453-8.

  38. Kho CM, Liew CF, Chew SK, Tai ES. The impact of central obesity as a prerequisite for the diagnosis of metabolic syndrome. Obesity (Silver Spring). 2007;15:262-9.

  39. Chatuverdi N. Differing aspects of insulin resistance in diabetes complications: The shape of things to come. RD Lawrence Lecture. 2000. Diabet Med. 2002;19(12):973-7.

  40. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva, World Health Organization; 1999.

  41. Shalitin S, Abrahami M, Lilos P, Phillip M. Insulin resistance and impare glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. International Journal of Obesity. 2005;29:571-8.

  42. Cabrera-Rode E, Marichal S, Parlá J, Arranz C, González R, Pérez C, et al. Frequency and characteristics of metabolic syndrome and insulin resistance in the first-degree relatives of persons with type 1 diabetes. Endocrinol Nutr. 2010;57:311-21.

  43. Goran MI, Coronges K, Bergman RN, Cruz ML, Gower B. Influence of family history of type 2 diabetes on insulin sensitivity in prepuberal children. J Clin Endocrinol Metab. 2003;88:192-5.

  44. Pan Y, Pratt CA. Metabolic syndrome and its association with diet and physical activiti in US adolescents. J Am Diet Assoc. 2008 Feb;108(2):276-86.

  45. Guangwei Li, Ping Zhang, Jinping Wang. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20 year follow-up study. Lancet. 2008;371:1 783-9.




2020     |     www.medigraphic.com